BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36858518)

  • 1. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
    Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
    Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series.
    Tahir A; McLaughlin K; Kline G
    BMC Endocr Disord; 2016 Jul; 16(1):43. PubMed ID: 27460219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.
    Taniguchi R; Koshiyama H; Yamauchi M; Tanaka S; Inoue D; Sato Y; Sugawa A; Muramatsu Y; Sasano H
    Tohoku J Exp Med; 1998 Nov; 186(3):215-23. PubMed ID: 10348217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
    An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.
    Fischer E; Hanslik G; Pallauf A; Degenhart C; Linsenmaier U; Beuschlein F; Bidlingmaier M; Mussack T; Ladurner R; Hallfeldt K; Quinkler M; Reincke M
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3965-73. PubMed ID: 22893716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.
    Shariq OA; Bancos I; Cronin PA; Farley DR; Richards ML; Thompson GB; Young WF; McKenzie TJ
    Surgery; 2018 Jan; 163(1):183-190. PubMed ID: 29129366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy - case report and discussion.
    Kanarek-Kucner J; Stefański A; Barraclough R; Gorycki T; Wolf J; Narkiewicz K; Hoffmann M
    Blood Press; 2018 Oct; 27(5):304-312. PubMed ID: 29742971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.
    Hibi Y; Hayakawa N; Hasegawa M; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Yuzawa Y; Itoh M; Iwase K
    Surg Today; 2015 Feb; 45(2):241-6. PubMed ID: 24343173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.
    Hoshi S; Onagi A; Tanji R; Honda-Takinami R; Matsuoka K; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
    BMC Endocr Disord; 2023 Nov; 23(1):243. PubMed ID: 37932696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
    Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
    J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Function Evolution and Hypoaldosteronism Risk After Unilateral Adrenalectomy for Primary Aldosteronism.
    Queiroz NL; Stumpf MAM; Souza VCM; Maciel AAW; Fagundes GFC; Okubo J; Srougi V; Tanno FY; Chambo JL; Pereira MAA; Pio-Abreu A; Bortolotto LA; Latronico AC; Barisson Villares Fragoso MC; Drager LF; Mendonça BB; Almeida MQ
    Horm Metab Res; 2024 May; 56(5):350-357. PubMed ID: 38040032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism.
    Huang WT; Chau T; Wu ST; Lin SH
    Clin Nephrol; 2010 May; 73(5):392-7. PubMed ID: 20420801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.
    Voss N; Mørup S; Clausen C; Feltoft CL; Jepsen JV; Hornum M; Andreassen M; Krogh J
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):306-314. PubMed ID: 36263597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
    Chiang WF; Cheng CJ; Wu ST; Sun GH; Lin MY; Sung CC; Lin SH
    Clin Chim Acta; 2013 Sep; 424():114-8. PubMed ID: 23727469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
    Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
    Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
    Wada N; Baba S; Sugawara H; Miyoshi A; Obara S
    Endocr J; 2023 Sep; 70(9):917-924. PubMed ID: 37423737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
    Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.